Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filio Billia

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
Journal of Cardiac Surgery|October 18, 2021
Association between time to therapeutic INR and length of stay following mechanical heart valve surgeryLucas C Godoy, George Tomlinson, Asmaa M Abumuamar, et al.
JACC. Clinical Electrophysiology|November 24, 2018
Safety of Chronic Cardiac Ryanodine Receptor Modulation: A 10-Year ExperienceMahmoud M Bokhari, Danna A Spears, Patrick F Lai, et al.
European Journal of Hybrid Imaging|December 16, 2021
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosisEdward Cheung, Sarah Ahmad, Matthew Aitken, et al.
ESC Heart Failure|February 10, 2025
Heart failure decompensation with cardiogenic shock exhibits distinct sequential inflammatory profilesDarshan H Brahmbhatt, Fernando Luis Scolari, Nicole L Fung, et al.
Circulation|November 29, 2012
A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesityMohammad Hossein Noyan-Ashraf, Eric Akihiko Shikatani, Irmgard Schuiki, et al.
Global Heart|May 1, 2023
The Guyana Program to Advance Cardiac Care: A Model for Equitable Cardiovascular Care DeliverySheila L Klassen, Karen Then, J Wayne Warnica, et al.
European Journal of Heart Failure|August 2, 2024
Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathyFernando L Scolari, Darshan Brahmbhatt, Sagi Abelson, et al.
Cell Reports. Medicine|April 20, 2024
Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correctionCaroline Kinnear, Abdelrahman Said, Guoliang Meng, et al.
Heart (British Cardiac Society)|December 6, 2018
Right ventricular fibrosis is associated with cardiac remodelling after pulmonary valve replacementKenichiro Yamamura, Darren Yuen, Edward J Hickey, et al.
The American Journal of Cardiology|September 19, 2016
A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac SupportGarry R Thomas, Michael A McDonald, Jennifer Day, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Journal of Cardiac Surgery|October 18, 2021
Association between time to therapeutic INR and length of stay following mechanical heart valve surgeryLucas C Godoy, George Tomlinson, Asmaa M Abumuamar, et al.
JACC. Clinical Electrophysiology|November 24, 2018
Safety of Chronic Cardiac Ryanodine Receptor Modulation: A 10-Year ExperienceMahmoud M Bokhari, Danna A Spears, Patrick F Lai, et al.
European Journal of Hybrid Imaging|December 16, 2021
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosisEdward Cheung, Sarah Ahmad, Matthew Aitken, et al.
ESC Heart Failure|February 10, 2025
Heart failure decompensation with cardiogenic shock exhibits distinct sequential inflammatory profilesDarshan H Brahmbhatt, Fernando Luis Scolari, Nicole L Fung, et al.
Circulation|November 29, 2012
A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesityMohammad Hossein Noyan-Ashraf, Eric Akihiko Shikatani, Irmgard Schuiki, et al.
Global Heart|May 1, 2023
The Guyana Program to Advance Cardiac Care: A Model for Equitable Cardiovascular Care DeliverySheila L Klassen, Karen Then, J Wayne Warnica, et al.
European Journal of Heart Failure|August 2, 2024
Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathyFernando L Scolari, Darshan Brahmbhatt, Sagi Abelson, et al.
Cell Reports. Medicine|April 20, 2024
Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correctionCaroline Kinnear, Abdelrahman Said, Guoliang Meng, et al.
Heart (British Cardiac Society)|December 6, 2018
Right ventricular fibrosis is associated with cardiac remodelling after pulmonary valve replacementKenichiro Yamamura, Darren Yuen, Edward J Hickey, et al.
The American Journal of Cardiology|September 19, 2016
A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac SupportGarry R Thomas, Michael A McDonald, Jennifer Day, et al.
Pageof 17